deltatrials

Stage iv breast cancer ajcc v6 and v7 Trials in Lancaster, United States

Conditions / Stage iv breast cancer ajcc v6 and v7 / Lancaster, United States

Research into Stage iv breast cancer ajcc v6 and v7 spans multiple therapeutic approaches and trial phases.

15 total trials for this combination

Showing top 10 of 15 trials

Trials

NCT ID Title Status Phase
NCT03633331 Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer COMPLETED
NCT00699491 Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer COMPLETED PHASE1/PHASE2
NCT02311933 Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer ACTIVE_NOT_RECRUITING
NCT03199885 Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer COMPLETED PHASE3
NCT05334069 Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection RECRUITING
NCT02595905 Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases COMPLETED PHASE2
NCT00785291 Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer COMPLETED PHASE3
NCT00684983 Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer COMPLETED PHASE2
NCT00601900 Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer COMPLETED PHASE3
NCT00390455 Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive COMPLETED PHASE3

Related Pages